Northern Gritstone
Northern Gritstone Limited (Companies House 12982592) is a permanent-capital investment company founded in October 2020 by the Universities of Manchester, Leeds and Sheffield to back deep-tech and life-science spinouts from Northern England. Authorised and regulated by the UK Financial Conduct Authority under firm reference number 1007673 (Northern Gritstone Investment Manager Limited). The company operates as a balance-sheet investor raising permanent capital from institutional investors: first close GBP 215 million (May 2022), final close GBP 312 million (October 2023), and further closes bringing total permanent capital to GBP 382 million by 2026. It has made over 30 investments across semiconductor design, novel materials, secure computing, AI, healthtech and gene therapies.
Key facts
Recent exits
Coverage notes
1 fund tracked, 31 portfolio companies (30 active · 1 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Northern Gritstone has raised, with its portfolio companies. Hand-checked from public filings.
Northern Gritstone EvergreenEvergreen2020 · 6yr€447M30 active · 1 realized
Unrealized
30 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| adsilico | HealthTech | UK | 2024 |
| AmpliSi | Deep Tech | UK | 2026 |
| Apini Therapeutics | Biotech | UK | 2025 |
| AssetCool | Deep Tech | UK | 2023 |
| Auxetec | Deep Tech | UK | 2023 |
| Cavero Quantum | Cybersecurity | UK | 2024 |
| Crucible Therapeutics | Biotech | UK | 2023 |
| Cytotrait | AgTech | UK | 2026 |
| Exciting Instruments | Deep Tech | UK | 2024 |
| Floreon | Deep Tech | UK | 2023 |
| Iceotope | Deep Tech | UK | 2022 |
| Imperagen | Biotech | UK | 2022 |
| IVFmicro | MedTech | UK | 2025 |
| Literal Labs | AI/ML | UK | 2025 |
| MicroLub | FoodTech | UK | 2024 |
| Mimetrik | HealthTech | UK | 2023 |
| OLO Robotics | Deep Tech | UK | 2025 |
| Optalysys | Deep Tech | UK | 2023 |
| Opteran | Deep Tech | UK | 2022 |
| Partful | SaaS | UK | 2024 |
| Pencil Biosciences | Biotech | UK | 2023 |
| Phagenesis | MedTech | UK | 2024 |
| Phlux | Deep Tech | UK | 2022 |
| PhovIR | Deep Tech | UK | 2025 |
| Pragmatic Semiconductor | Deep Tech | UK | 2023 |
| QV Bioelectronics | MedTech | UK | 2023 |
| Re:course | HealthTech | UK | 2023 |
| Silveray | Deep Tech | UK | 2023 |
| SimAnalytica | SaaS | UK | 2023 |
| Sitehop | Cybersecurity | UK | 2025 |
Saved GPs appear in your watchlist, one click from your workspace.
About Northern Gritstone
Northern Gritstone is a place-based university spin-out investor with approximately £312 million of assets under management as of December 2024 (final close November 2023, further £20 million added 2024-2025, £500 million long-term target), headquartered in Manchester with offices in Leeds, Sheffield and London. The firm was founded in 2021 as a joint venture tied to the Universities of Manchester, Leeds and Sheffield, operating as an independent investment company with Northern Gritstone Investment Manager Ltd FCA-regulated and backed by pension funds, M&G, Columbia Threadneedle, British Patient Capital, Lansdowne Partners and Bruntwood.
Investment thesis
Northern Gritstone deploys capital through a single pooled vehicle, targeting university spin-out and early-stage deep tech and life sciences investing with a 'profit with purpose' approach. Sector focus spans deep tech, life sciences, semiconductors, quantum computing, bioelectronics and therapeutics and climate tech. Geographic deployment is the North of England, commercialising research from the Universities of Manchester, Leeds, Liverpool and Sheffield to drive regional economic impact.
Recent activity
Realised exits have not been reported across 2024-2026 reflecting the young portfolio of 23 plus companies. Recent acquisitions include a semiconductor spin-out follow-on, bioelectronics and pre-seed silicon and imaging tech (2024-2025). The platform continues active deployment across the Northern England university spin-out mandate. Detailed buyer names and multiple data available on Pro at €29/month.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.